BELVIN MARCIA

CIK 00019707521 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001970752

Recent Transactions

29 trades

Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2026-02-02+250,000→ 250,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2026-02-02+60,000→ 332,252 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-09-26+36,300→ 36,300 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2025-09-26+18,150→ 18,150 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-06-16$2.69/sh−13,884→ 272,252 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units
2025-06-13−37,500→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-06-13+37,500→ 286,136 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-03-18$0.60/sh−19,512→ 248,636 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+115,000→ 115,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+57,500→ 263,148 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+30,000→ 205,648 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+140,000→ 140,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+35,000→ 210,648 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+57,500→ 268,148 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+115,000→ 115,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+150,000→ 150,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20$1.23/sh−4,181→ 175,648 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-08-20−11,250→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20+11,250→ 179,829 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-03-19$2.09/sh−12,795→ 168,579 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-01-18+75,000→ 75,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-01-18+26,250→ 181,374 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-01-18+122,500→ 122,500 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-20$1.38/sh−4,077→ 155,124 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-17+11,250→ 159,201 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-12-17−11,250→ 11,250 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-22$1.30/sh−4,119→ 147,951 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-20+11,250→ 152,070 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-03-22+60,000→ 140,820 total

Companies

CytomX Therapeutics, Inc.
SVP, Chief Scientific Officer
$CTMX

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov